WO2007038610A3 - Use of natural products for treatment of neurological disorders - Google Patents

Use of natural products for treatment of neurological disorders Download PDF

Info

Publication number
WO2007038610A3
WO2007038610A3 PCT/US2006/037692 US2006037692W WO2007038610A3 WO 2007038610 A3 WO2007038610 A3 WO 2007038610A3 US 2006037692 W US2006037692 W US 2006037692W WO 2007038610 A3 WO2007038610 A3 WO 2007038610A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
natural products
neurological disorders
extracts
prevention
Prior art date
Application number
PCT/US2006/037692
Other languages
French (fr)
Other versions
WO2007038610A2 (en
Inventor
Steven C Schachter
Original Assignee
Harvard College
Steven C Schachter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Steven C Schachter filed Critical Harvard College
Publication of WO2007038610A2 publication Critical patent/WO2007038610A2/en
Publication of WO2007038610A3 publication Critical patent/WO2007038610A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention is directed to methods and compositions for using extracts, compounds isolated from natural products and functional analogs thereof for the prevention and/or treatment of neurological seizures such as those associated with epilepsy. The invention is also directed to methods and compositions for using extracts, compounds isolated from natural products and functional analogs thereof for the prevention and/or treatment of neurological disorders.
PCT/US2006/037692 2005-09-26 2006-09-26 Use of natural products for treatment of neurological disorders WO2007038610A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72059905P 2005-09-26 2005-09-26
US60/720,599 2005-09-26
US74944405P 2005-12-09 2005-12-09
US60/749,444 2005-12-09

Publications (2)

Publication Number Publication Date
WO2007038610A2 WO2007038610A2 (en) 2007-04-05
WO2007038610A3 true WO2007038610A3 (en) 2007-10-25

Family

ID=37900423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/037692 WO2007038610A2 (en) 2005-09-26 2006-09-26 Use of natural products for treatment of neurological disorders

Country Status (1)

Country Link
WO (1) WO2007038610A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103908596A (en) * 2014-04-21 2014-07-09 柳少逸 Traditional Chinese medicament for treating epilepsy
CN104415044A (en) * 2013-08-30 2015-03-18 陈震 Pharmaceutical composition and preparation thereof for treating stroke and sequelae thereof
CN112957527B (en) * 2021-03-23 2021-11-23 武汉理工大学 Conductive nerve conduit and preparation method thereof

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008003467A1 (en) * 2008-01-02 2009-09-10 Eiden, Martin, Dr. Flavonoids as agents for the prophylaxis and treatment of neurodegenerative and other protein deficiency diseases
CN101677989B (en) * 2008-02-14 2012-10-10 清华大学 A drug composition for treatment and prevention of ischemic stroke and its preparation methods
CN102125575A (en) * 2010-01-19 2011-07-20 张作光 Application of albiflorin in resisting Parkinson's disease
BRPI1001988A2 (en) * 2010-01-20 2012-05-22 Luiz Francisco Pianowski use of at least one isoquinolytic compound of formula I, pharmaceutical composition for treating or preventing neurodegenerative disorders and method for treating or preventing neurodegenerative disorders
DK2644198T3 (en) * 2010-11-25 2017-07-17 Zuoguang Zhang ANTIANXIETY AND SLEEP DISORDER IMPROVING USE OF ALBIFLORIN
US20120245190A1 (en) * 2011-03-23 2012-09-27 Hong Kong Baptist University Autophagy inducing compound and the uses thereof
CN102648895B (en) * 2012-04-16 2013-08-14 丁丽曼 Application of gastrodin injection in preparing medicine for treating chronic gastritis
CN102716343B (en) * 2012-06-02 2013-10-09 蒋勇 Traditional Chinese medicine composite for treating epileptic disease of calf
CN103030674B (en) * 2012-12-13 2016-05-25 大兴安岭林格贝寒带生物科技股份有限公司 In a kind of wintergreen, extract the production method of Hyperoside
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN103224539B (en) * 2013-05-23 2015-09-09 湖北济生医药有限公司 A kind of Gastrodine compound and pharmaceutical composition thereof
CN103520095B (en) * 2013-10-25 2015-07-01 江西国药有限责任公司 Gastrodin injection and preparation process thereof
CN103788148B (en) * 2014-02-13 2015-11-04 悦康药业集团有限公司 Gastrodin compound and preparation thereof
CN104231013B (en) * 2014-08-26 2016-06-29 上海现代哈森（商丘）药业有限公司 A kind of gastrodine Glehnilae and preparation method thereof and application
JP6850164B2 (en) * 2016-03-14 2021-03-31 サントリーホールディングス株式会社 Bitterness inhibitor and bitterness inhibitor
EP3566707A4 (en) * 2017-01-06 2020-08-19 Zuoguang Zhang Application of albiflorin as indoleamine 2,3-dioxygenase (ido) inhibitor
CN108671155A (en) * 2018-07-24 2018-10-19 李靖 It is a kind of to be used to treat Chinese medicine composition of epilepsy and preparation method thereof
KR102124880B1 (en) * 2018-11-01 2020-07-07 명지대학교 산학협력단 Composition for preventing or treating peripheral neuropathy comprisiong decursin or derivates thereof
CN113453691A (en) * 2019-02-21 2021-09-28 张作光 Application of albiflorin in preparation of medicine for rapidly treating depression
CN110214972B (en) * 2019-05-28 2020-06-16 王敏 Cigarette additive and preparation method and application thereof
CN110755632A (en) * 2019-11-28 2020-02-07 四川大学 Brain-targeting rhynchophylline nano preparation, preparation method and application in intravenous injection medicine
CN111869863B (en) * 2020-07-24 2023-08-22 聊城大学 A medium chain triglyceride ketogenic diet composition containing Chinese medicinal active ingredients, and its preparation method and application
CN114573649A (en) * 2020-11-30 2022-06-03 昆药集团股份有限公司 High-purity gastrodin crystal and preparation method and application thereof
CN114573647A (en) * 2020-11-30 2022-06-03 昆药集团股份有限公司 Gastrodin anhydrous crystal form and preparation method thereof
CN113968837B (en) * 2021-11-12 2022-09-06 中国科学院兰州化学物理研究所 Compound with antiepileptic activity and application thereof in preparing antiepileptic medicine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225203A (en) * 1987-07-01 1993-07-06 Kim Young S Pharmaceutical liquid composition containing Bezoar bovis
US20020031559A1 (en) * 2000-03-08 2002-03-14 Liang Kin C. Herbal suppositories
US20030207270A1 (en) * 2001-03-09 2003-11-06 Kung Patrick C. Phytomics: a genomic-based approach to herbal compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225203A (en) * 1987-07-01 1993-07-06 Kim Young S Pharmaceutical liquid composition containing Bezoar bovis
US5225203C1 (en) * 1987-07-01 2001-05-15 Kim Won Kyq Son Pharmaceutical liquid composition containing bezoar bovis
US20020031559A1 (en) * 2000-03-08 2002-03-14 Liang Kin C. Herbal suppositories
US20030207270A1 (en) * 2001-03-09 2003-11-06 Kung Patrick C. Phytomics: a genomic-based approach to herbal compositions

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] OHNISHI N.: "Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats", accession no. NCBI Database accession no. (11554427) *
DATABASE MEDLINE [online] SHUKIA B.: "Effect of Brahmi Rasayan on the central nervous system", accession no. NCBI Database accession no. (3695557) *
DATABASE MEDLINE [online] SUGAYA E.: "Regulation of gene expression by herbal medicines-a new paradigm of gene therapy for multifocal abnormalities of genes", accession no. NCBI Database accession no. (11485047) *
DATABASE MEDLINE [online] SUNAGAWA M.: "Effectiveness of Saiko-Keishi-To (TJ-10, a Kampo herbal medicine) for trigeminal neuralgia in rats", accession no. NCBI Database accession no. (11424461) *
EUR. J. DRUG. METAB. PHARMACOKINET., vol. 26, no. 1-2, January 2001 (2001-01-01) - June 2001 (2001-06-01), pages 129 - 135 *
J. ETHNOPHARMACOL., vol. 21, no. 1, September 1987 (1987-09-01) - October 1987 (1987-10-01), pages 65 - 74 *
MASUI, vol. 50, no. 5, May 2001 (2001-05-01), pages 486 - 490 *
RES. COMMUN. MOL. PATHOL. PHARMACOL., vol. 106, no. 3, 1999, pages 171 - 180 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104415044A (en) * 2013-08-30 2015-03-18 陈震 Pharmaceutical composition and preparation thereof for treating stroke and sequelae thereof
CN104415044B (en) * 2013-08-30 2018-10-16 陈震 A kind of pharmaceutical composition and its preparation for treating apoplexy and its sequelae
CN103908596A (en) * 2014-04-21 2014-07-09 柳少逸 Traditional Chinese medicament for treating epilepsy
CN112957527B (en) * 2021-03-23 2021-11-23 武汉理工大学 Conductive nerve conduit and preparation method thereof

Also Published As

Publication number Publication date
WO2007038610A2 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
WO2007038610A3 (en) Use of natural products for treatment of neurological disorders
WO2008011476A3 (en) Compositions and methods for modulating sirtuin activity
WO2007064883A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2009133573A3 (en) A homeopathic formulation
WO2007009120A3 (en) Heterotetracyclic compounds as tpo mimetics
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2007002884A3 (en) 4-fluoro-piperidine t-type calcium channel antagonists
WO2007126934A3 (en) Amidoethylthioether orexin receptor antagonists
WO2007025069A3 (en) Diazaspirodecane orexin receptor antagonists
WO2006083533A3 (en) Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders
WO2008008551A3 (en) 2-substituted proline bis-amide orexin receptor antagonists
WO2007089557A3 (en) Polycyclic 1, 2, 3, 4 -tetrahydro- isoquinoline derivatives and compositions comprising them as ppar modulators
WO2008036653A3 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
WO2008036642A3 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
WO2007121188A3 (en) Compositions and methods of using r(+) pramipexole
WO2007002361A3 (en) 3-fluoro-piperidine t-type calcium channel antagonists
WO2011069063A3 (en) Multicyclic compounds and methods of use thereof
WO2008011363A3 (en) Quercetin-containing compositions
WO2006131322A3 (en) Use op brivaracetam for the treatment of diseases characterized by progressive myoclonic epilepsy
WO2006034154A3 (en) Salts of 5-azacytidine
WO2007022269A3 (en) Compounds and compositions as tpo mimetics
WO2007067511A3 (en) Morpholine carboxamide prokineticin receptor antagonists
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2007056366A3 (en) Compounds and compositions as ppar modulators

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06825172

Country of ref document: EP

Kind code of ref document: A2